Skip to main content
. 2018 Dec 18;10(4):286. doi: 10.3390/pharmaceutics10040286

Figure 5.

Figure 5

Figure 5

PS surface exposure of NRBCs and BSP-RBCs. (A) FSC-SSC scatter plot; (B) PS reversion rate. Data are represented as mean ± SD, three samples were used in each group. ** correspond to p < 0.01.